Teacher Retirement System Of Texas Allakos Inc. Transaction History

Teacher Retirement System Of Texas

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$2.13 - $5.55 $1,365 - $3,557	641 Added 5.52%	12,249 $28,000
Q2 2023 Jul 19, 2023	SELL	$3.6 - $5.25 $730 - $1,065	-203 Reduced 1.72%	11,608 $51,000
Q1 2023 May 12, 2023	SELL	$4.3 - $8.27 $31,918 - $61,388	-7,423 Reduced 38.59%	11,811 $53,000
Q4 2022 Feb 10, 2023	BUY	$5.66 - $8.42 $108,864 - $161,950	19,234 New	19,234 $162,000
Q4 2021 Feb 10, 2022	SELL	$8.55 - $111.89 $43,391 - $567,841	-5,075 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$76.53 - $110.43 $73,545 - $106,123	961 Added 23.36%	5,075 $537,000
Q2 2021 Aug 05, 2021	BUY	$85.37 - $114.1 $116,700 - $155,974	1,367 Added 49.76%	4,114 $351,000
Q1 2021 May 11, 2021	BUY	$109.73 - $153.66 $56,181 - $78,673	512 Added 22.91%	2,747 $315,000
Q4 2020 Feb 11, 2021	BUY	$79.58 - $152.45 $177,861 - $340,725	2,235 New	2,235 $313,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.